Effect of truncated-ApoE4 overexpression on tau phosphorylation in cultured N2a cells

  • Zhou Jie
  • Chen Juan
  • Feng Youmei


The carboxyl-terminal amino acids 272–299-truncated apoE4 (Δ272–299) is the main fragments of apoE4 hydrolysate in neurons. The effects of truncated-ApoE4 (Δ272–299) overexpression on tau phosphorylation in cultured N2a cells were investigated. The truncated-apoE4 (Δ272–299) cDNA was subcloned into pEGFP-c3 to form recombinant pEGFP-T-apoE4. pEGFP-c3, pEGFP-T-apoE4 and pEGFP-apoE4 were transfected into N2a cells respectively by lipofectamine 2000 method. After 24–48 h, tau phosphorylation was detected by Western blot assay and glycogen synthase kinase-3 (GSK-3) activity by using GSK-3 activity assay. The results showed that the overexpression of both full length-apoE4 and truncated apoE4 fragments in N2a cells induced a dramatic increase in phosphorylation of tau at Ser202 sites and the activation of GSK-3 as compared with untransfected cells, most significantly in the cells transfected with pEGFP-T-apoE4 (P<0.05). It as concluded that in vitro overexpression of truncated-ApoE4 (Δ272–299) can result in tau hyperphosphorylation in N2a cells by activating GSK-3, suggesting truncated-ApoE4 (Δ272–299) might contribute the pathogenesis of Alzheimer disease.

Key words

truncated-ApoE4 tau glycogen synthase kinase-3 Alzheimer disease 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Fagan A M, Holtzman D M. Astrocyte lipoproteins, effects of apoE on neuronal function, and role of apoE in amyloid-beta deposition in vivo. Microsc Res Tech, 2000, 50 (4): 297–304PubMedCrossRefGoogle Scholar
  2. 2.
    Hans H. Bock, Yves Jossin. Phosphatidylinositol 3-kinase interacts with the adaptor protein Dab1 in response to Reelin signaling and is required for normal cortical lamination. J Biol Chem, 2003, 278 (40): 38 772–38 779Google Scholar
  3. 3.
    Huang Y D, Liu X Q. Apolipoprotein E fragments present in Alzheimer’s disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons. Proc Natl Acad Sci USA, 2001, 98 (15): 8838–8843PubMedCrossRefGoogle Scholar
  4. 4.
    Han X L, Cheng H. Novel role for apolipoprotein E in the central nervous system. J Biol Chem, 2003, 278 (10): 8043–8051PubMedCrossRefGoogle Scholar
  5. 5.
    Cedazo-Minguez A, Popescu B, Blanco-Millan J Met al. Apolipoprotein E and beta-amyloid (1–42) regulation of glycogen synthase kinase-3beta. J Neurochem, 2003, 87 (5): 1152–1164PubMedCrossRefGoogle Scholar
  6. 6.
    Ye S M, Huang Y D, Mullendorff Ket al. Apolipoprotein (apo) E4 enhances amyloid peptide production in cultured neuronal cells: ApoE structure as a potential therapeutic target. PNAS, 102 (52): 18 700–18 705Google Scholar
  7. 7.
    Kosik K S. The molecular and cellular biology of tau. Brain Pathol, 1993, 3 (1): 39–43PubMedCrossRefGoogle Scholar
  8. 8.
    Goedert M. tau protein and the neurofibrillary pathology of Alzheimer’s disease. Trends Neurosci, 1993, 16: 460–465PubMedCrossRefGoogle Scholar
  9. 9.
    Pei J J, Tanaka T, Tung Y Cet al. Distribution, levels, and activity of GSK-3 in the Alzheimer disease brain. J Neuropathol Exp Neurol, 1997, 56: 70–78PubMedCrossRefGoogle Scholar

Copyright information

© Springer 2006

Authors and Affiliations

  • Zhou Jie
    • 1
  • Chen Juan
    • 1
  • Feng Youmei
    • 1
  1. 1.Department of Biochemistry and Molecular Biology, Tongji Medical CollegeHuazhong University of Science and TechnologyWuhanChina

Personalised recommendations